Piper Jaffray Downgrades Aslan Pharma (ASLN) to Neutral
Tweet Send to a Friend
Piper Jaffray analyst Edward Tenthoff downgraded Aslan Pharma (NASDAQ: ASLN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
